Cystic fibrosis

From The School of Biomedical Sciences Wiki
(Difference between revisions)
Jump to: navigation, search
Line 35: Line 35:
[[Gene therapy|Gene Therapy]]  
[[Gene therapy|Gene Therapy]]  
[[Pharmacotherapy of Cystic Fibrosis|Pharmacotherapy]]  
[[Alternative Channel Therapy|Alternative Channel Therapy]]  
[[Alternative Channel Therapy|Alternative Channel Therapy]]  

Revision as of 11:45, 8 November 2010


Cystic Fibrosis

Cystic Fibrosis is an autosomal recessive disease located on chromosome 7. Cystic Fibrosis is caused by a mutation to the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) channel. The most common mutation is ΔF508, accounting for 70% of mutations in the Caucasin UK population, in which the triplet code for the amino acid phenylalanine is deleted, disrupting Cl- transport. This mutation belongs to the Class II group of mutations causing Cystic Fibrosis.

Classes of CFTR Mutations

Class I: Premature Stop Codons

Class II: Abnormal Processing

Class III: Altered Regulation

Class IV: Conductance Defect

Class V: Reduced Protein Synthesis


Approaches to Treatment

Lung Function

Physiotherapy and mucolytics

Oral and Inhaled Antibotics

Anti-Inflammatory Drugs

Lung Transplant

Gene Therapy


Alternative Channel Therapy

Pancreatic Function

Pancreatic Enzyme Replacement

Nutrional Regime

Personal tools